CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia

被引:16
作者
De Andrade, Camilla F. C. G. [1 ]
Bigni, Ricardo
Pombo-De-Oliveira, Maria S. [2 ]
Alves, Gilda [1 ]
Pereira, Denise A. [1 ]
机构
[1] Hosp Canc 1, Lab Genet Aplicada, Serv Hematol, Inst Nacl Canc, BR-20230130 Rio De Janeiro, Brazil
[2] Inst Nacl Canc, Div Expt Med, BR-20231050 Rio De Janeiro, Brazil
关键词
CD26; DPPIV; dipeptidyl peptidase; leukemia; immunophenotype; sitagliptin; inhibition; DIPEPTIDYL-PEPTIDASE-IV; ACUTE LYMPHOBLASTIC-LEUKEMIA; ADENOSINE-DEAMINASE BINDING; AMINO-TERMINAL TRUNCATION; CD26/DIPEPTIDYL-PEPTIDASE IV; FUNCTIONAL-ROLE; LIPID RAFTS; CORD BLOOD; T-CELLS; IN-VIVO;
D O I
10.1080/14756360802334800
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD26/DPPIV (dipeptidil peptidase IV) displays an array of diverse functional properties, with a role in the development of several human cancers. This enzyme is found mainly anchored in the membrane of cells although it also has an enzymatically active plasma isoform. The regulation of biological activities of cytokines by DPP IV activity has a potential role in the homeostatic regulation of hematopoiesis. In this study, we analyzed the CD26 antigen cell membrane expression by flow cytometry and the DPPIV activity in plasma of patients of acute leukemia. The results showed that the plasma DPPIV activity is significantly higher in leukemia patients and could be 100% inhibited by Januvia(TM) (Merck Sharp & Dohme) a selective DPPIV inhibitor. Although CD26 expression on immune cells were not leukemia-dependent the analysis of the correlation between CD26 expression and the DPPIV plasma activity were statistically significant (p < 0.01) in acute lymphoid leukemia (B-ALL and T-ALL).
引用
收藏
页码:708 / 714
页数:7
相关论文
共 35 条
[1]   Activation antigen expression on human T cells .1. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue [J].
Amlot, PL ;
Tahami, F ;
Chinn, D ;
Rawlings, E .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01) :176-182
[2]  
BANI B, 1997, LEUKEMIA DIAGNOSIS
[3]  
BENE MC, 1995, LEUKEMIA, V9, P1783
[4]   KINETICS OF DIPEPTIDYL PEPTIDASE-IV PROTEOLYSIS OF GROWTH HORMONE-RELEASING FACTOR AND ANALOGS [J].
BONGERS, J ;
LAMBROS, T ;
AHMAD, M ;
HEIMER, EP .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1122 (02) :147-153
[5]  
BUHLING F, 1994, NAT IMMUN, V13, P270
[6]   FUNCTIONAL-ROLE OF CD26 ON HUMAN B-LYMPHOCYTES [J].
BUHLING, F ;
JUNKER, U ;
REINHOLD, D ;
NEUBERT, K ;
JAGER, L ;
ANSORGE, S .
IMMUNOLOGY LETTERS, 1995, 45 (1-2) :47-51
[7]   Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer [J].
Busek, P ;
Malík, R ;
Sedo, A .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (03) :408-421
[8]  
Dang NH, 2002, HISTOL HISTOPATHOL, V17, P1213, DOI 10.14670/HH-17.1213
[9]   CD26, let it cut or cut it down [J].
De Meester, I ;
Korom, S ;
Van Damme, J ;
Scharpé, S .
IMMUNOLOGY TODAY, 1999, 20 (08) :367-375
[10]  
Dong RP, 1997, J IMMUNOL, V159, P6070